score_bin	sensitive_predictive_implication	resistance_predictive_implication	prognostic_predictive_implication	feature_type	feature	alteration_type	alteration	tumor_f	total_coverage	exac_af	exac_common	clinvar	sensitive_score_bin	sensitive_therapy_name	sensitive_therapy_strategy	sensitive_therapy_type	sensitive_description	sensitive_citation	sensitive_url	resistance_score_bin	resistance_therapy_name	resistance_therapy_strategy	resistance_therapy_type	resistance_description	resistance_citation	resistance_url	prognostic_score_bin	favorable_prognosis	prognostic_description	prognostic_citation	prognostic_url	number_germline_mutations_in_gene	validation_total_coverage	validation_tumor_f	validation_detection_power	feature_display	preclinical_efficacy_observed	patient_id	tumor_sample_barcode	normal_sample_barcode
Investigate Actionability	Preclinical		Clinical trial	Somatic Variant	PIK3CA	Missense	p.V71I	0.015	333.0	8e-06	0.0		Investigate Actionability	Pictilisib	PI3K/AKT/mTOR inhibition	Targeted therapy	In vivo models harboring PIK3CA variants were especially sensitive to GDC-0941.	O'Brien C, Wallin JJ, Sampath D, et al. Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models. Clin Cancer Res. 2010;16(14):3670-83.	https://doi.org/10.1158/1078-0432.CCR-09-2828								Investigate Actionability	0.0	Median PFS was longer in patients with normal PTEN, TP53, and PIK3CA status.	Hussain M, Daignault-newton S, Twardowski PW, et al. Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012. J Clin Oncol. 2018;36(10):991-999.	https://doi.org/10.1200/JCO.2017.75.7310	0				PIK3CA p.V71I (Missense)	1.0	MEL-IPI_Pat167	MEL-IPI_Pat167-Tumor-SM-7A15H	MEL-IPI_Pat167-Normal-SM-5VWIR
Biologically Relevant				Copy Number	RAD51D	Deletion				0.0	0.0																					0				RAD51D Deletion		MEL-IPI_Pat167	MEL-IPI_Pat167-Tumor-SM-7A15H	
Biologically Relevant				Copy Number	ERG	Deletion				0.0	0.0																					0				ERG Deletion		MEL-IPI_Pat167	MEL-IPI_Pat167-Tumor-SM-7A15H	
Biologically Relevant				Copy Number	EML4	Deletion				0.0	0.0																					0				EML4 Deletion		MEL-IPI_Pat167	MEL-IPI_Pat167-Tumor-SM-7A15H	
Biologically Relevant				Copy Number	JAK2	Deletion				0.0	0.0																					0				JAK2 Deletion		MEL-IPI_Pat167	MEL-IPI_Pat167-Tumor-SM-7A15H	
Biologically Relevant				Microsatellite Stability	Supporting variants		PRDM2 p.703_704insP (Insertion)																									0				Supporting variants: PRDM2 p.703_704insP (Insertion)		MEL-IPI_Pat167		
Biologically Relevant				Mutational Signature	COSMIC Signature 1	version 2	0.646																									0				COSMIC Signature (version 2) 1 (65%)		MEL-IPI_Pat167		
